Skip to main content
. 2014 Jan 20;17(1):15–23. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2014.01.03

2.

2

局限期SCLC患者生存曲线（Log-rank检验）。A：疗前PS（ECOG）0、1、2（P=0.045）；B：胸部放疗（Yes）与未放疗（No）（P=0.026)；C：胸部同步放化疗（Concurrent）与序贯放疗（Sequential）（P=0.813)；D：早期同步放化疗（Early）与晚期同步放化疗（Late）(P=0.270)；E：PCI（Yes）与未行PCI（No）(P=0.288)。

Survival curves of SCLC patients in LD (Log-rank test). A: PS before treatment (ECOG) 0, 1, 2 (P=0.045); B: Thoracic radiotherapy (Yes) and no radiotherapy (No)(P =0.026); C: Thoracic concurrent chemoradiation and sequential chemoradiation (P=0.813); D: Early concurrent chemoradiation and late concurrent chemoradiation (P=0.270); E: PCI (Yes) and no PCI (No) (P=0.288).